Biotechnolgy &

There are over 19,000 emerging biotechnology and commercial biopharmaceutical companies around the world. How do you differentiate yourself and get above the noise to improve your odds of success? Over 300 companies served.
Featured Case Study


Preparing for an IPO and launching the first gene therapy in the western world

We quickly identified some major issues related to the company using their lead program, Glybera – the first gene therapy to be approved in the western world – as the foundation of their IPO. We repositioned the company around their platform and development capabilities, and set them up for success long-term.

Organizations we have served

Organizations we have launched

What we do

Our services

We build brands and implement communications strategies to help achieve your goals and objectives. We intimately know the audiences you want to reach including patients, clinicians, investors, partners, employees and the life science community at large.​

Let’s Talk

Contact us to learn more about how we can help you achieve your goals.